Multiple European healthcare databases possess sufficient data on ADHD diagnosis, drug exposure, and clinical outcomes to be used for multinational long-term safety studies of methylphenidate.
No takes yet. Share an insight, caveat, or question.
May enable multinational methylphenidate safety studies across European databases; leaves open definitive long-term risk estimates pending analyses.
Murray et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: